No connection

Search Results

NUS vs PM

NUS
Nu Skin Enterprises, Inc.
NEUTRAL
Price
$7.30
Market Cap
$359.0M
Sector
Consumer Defensive
AI Confidence
85%
PM
Philip Morris International Inc.
BULLISH
Price
$155.43
Market Cap
$241.95B
Sector
Consumer Defensive
AI Confidence
92%

Valuation

P/E Ratio
NUS
2.3
PM
22.17
Forward P/E
NUS
5.57
PM
21.59
P/B Ratio
NUS
0.44
PM
-22.17
P/S Ratio
NUS
0.24
PM
6.05
EV/EBITDA
NUS
2.92
PM
16.14

Profitability

Gross Margin
NUS
69.45%
PM
66.92%
Operating Margin
NUS
6.28%
PM
40.75%
Profit Margin
NUS
10.79%
PM
21.57%
ROE
NUS
22.0%
PM
--
ROA
NUS
3.95%
PM
14.94%

Growth

Revenue Growth
NUS
-16.9%
PM
9.4%
Earnings Growth
NUS
--
PM
13.1%

Financial Health

Debt/Equity
NUS
0.38
PM
--
Current Ratio
NUS
2.08
PM
0.85
Quick Ratio
NUS
1.07
PM
0.37

Dividends

Dividend Yield
NUS
3.29%
PM
3.78%
Payout Ratio
NUS
7.55%
PM
78.76%

AI Verdict

NUS NEUTRAL

NUS presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 and a bearish technical trend of 0/100. While the company is trading at a massive discount to its Graham Number ($34.57) and Intrinsic Value ($22.26), this is offset by a severe revenue contraction of -16.90% YoY. The balance sheet remains healthy with low debt (D/E 0.38) and strong liquidity, but the operational decay suggests the market is pricing in a permanent decline in the business model.

Strengths
Extremely low valuation (P/E 2.30, P/B 0.44)
Strong gross margins (69.45%)
Healthy liquidity with a Current Ratio of 2.08
Risks
Significant revenue decline (-16.90% YoY)
Weak operational health (Piotroski F-Score 3/9)
Severe long-term price erosion (-83.6% over 5 years)
PM BULLISH

Philip Morris International (PM) presents a compelling investment case supported by strong profitability, consistent earnings growth, and a resilient dividend profile. Despite near-term price weakness over the past six months (-7.3%), the stock has delivered exceptional long-term returns (+153.1% over 5Y), underpinned by robust YoY EPS growth of 17.3% and a track record of beating earnings estimates in 22 of the last 25 quarters. The company’s high operating margin (40.75%) and gross margin (66.92%) reflect pricing power and cost discipline in a defensive sector, while its forward P/E of 21.59 appears justified given growth and stability. Analysts concur with a unanimous buy rating and a $185.75 target price, implying ~19.5% upside, reinforcing confidence in continued outperformance.

Strengths
Exceptional profitability with operating margin of 40.75% and gross margin of 66.92%, among the highest in consumer defensive sector
Consistent earnings growth: 13.1% YoY and 17.3% most recent Q/Q EPS growth, demonstrating strong underlying momentum
Outstanding earnings surprise record: 22 out of 25 quarters beat estimates, with an average surprise of +4.82% over the last four
Risks
Negative Price/Book ratio (-22.17) suggests deep negative equity, likely due to aggressive share buybacks exceeding retained earnings
Weak liquidity profile: current ratio of 0.85 and quick ratio of 0.37 indicate potential near-term cash flow pressure
Missing key financials (debt/equity, EV, cash/debt) limits full health assessment and raises transparency concerns

Compare Another Pair

NUS vs PM: Head-to-Head Comparison

This page compares Nu Skin Enterprises, Inc. (NUS) and Philip Morris International Inc. (PM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile